| (1) |
Jennette JC., Falk RJ. Small Vessel Vasculitis. N Eng
J Med 1997; 337 (21): 1512-23. |
| (2) |
Bini P., Gabay JE., Teitel A., Melchior M., Zhou JL.,
Elkori KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis
recognize conformational epitope(s) on proteinase 3. J Immunol 1992; 149(4):
1409-15. |
| (3) |
Kerr Gs., Fleisher TA., Hallahan CW., Leavitt RY., Fauci
AS., Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic
antibody titer in paticnts with Wegener's granulomatosis. Arthritis and
Rheumatism 1993; 36(3): 365-71. |
| (4) |
Hauschild S., Schmitt WH., Csernok E., Flesch BK., Rautmann
A., Gross WL. ANCA in systemic vasculitides, collagen vascular diseases,
rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993;
336: 245-51. |
| (5) |
Davenport A., Lock RJ., Wallington TB., Feest TG. Clinical
signifieance of anti-neutrophil cytoplasm antibodies detected by a standardized
indirect immunofluorescence assay. QJM 1994; 87(5): 291-9. |
| (6) |
Dolman KM., Gans ROB., Vervaat TJ., et al, Vasculitis and antineutrophil
cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet
1993; 342: 651-2. |
| (7) |
Vogt BA., Kim Y., Jennette JC., Falk RJ., Burke BA.,
Sinaiko A. Antineutrophil cyloplasmic autoantibody-positive crescentic glomerulonephritis
as a complication of treatment with propylthiouracil in children. J Pediat
1994; 124(6): 986-8. |
| (8) |
Evangelos R., David RF., Bruce WK. Propylthiouracil Therapy: An unusual
cause of antineutrophil cytoplasmic antibody associated alveolar haemorrhage.
J Rheumatol 1995; 22: 803. |
| (9) |
Tanemoto M., Miyakawa H. , Hanai J., Yago M., Kitaoka
M., Uchida S. Myeloperoxidase-Antineutrophil Cyloplasmic Antibody-Positive
Crescentic Glomerulonephritis Complicating the Course of Graves' Disease:
Report of Three Adult Cases. Am J Kidney Dis 1995; 26(5): 774-80. |
| (10) |
Ito K.(PTU-induced vasculitis). Jpn J Nephrol 1994; 36: 1354. |
| (11) |
Kudo Y., Kuroda S., Shimamoto K., Iimura O. Propylthiouracil-induced
rapidly progressive glomerulonephritis associated with antineutrophil cyioplasmic
autoantibodies. Clin Nephrol 1997; 48(1): 41-3. |
| (12) |
Toda A.(PTU-induced vasculitis). Jpn J Nephrol 1995;
37: 701. |
| (13) |
Hirano K.(PTU-induced vasculitis). Jpn J Nephrol 1995;
37: 701. |
| (14) |
Aoki A., Suzuki H., Ohata T. et al. A case of P-ANCA
positive necrotizing vasculitis associated with Graves' disease. Ryumachi
1995; 35: 683. |
| (15) |
Stankus SJ., Johnson NT. Propylthiouracil-induced hypersensitivity
vasculitis presenting as respiratory failure. Chest 1992; 102: 1595-6. |
| (16) |
D'Cruz D., Chesser AMS., Lightowler C. et al. Antineutrophil cytoplasmic
antibody-positive crescentic glomerulonephritis associated with anti-thyroid
drug treatment. Br J Rheumatol 1995; 34: 1090-91. |
| (17) |
Kitahara T., Hiromura K., Maezawa A. et al. Case of
propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic
antibody (ANCA); review of the literature. Clin Nephrol 1997; 47: 336-40. |
| (18) |
Hori Y., Arizono K., Hara S., Kawai R., Hara M., Yamada A. Antineutrophil
Cyioplasmic Autoantibody-Positive Crescentic Glomerulonephritis Associated
with Thiamazole Therapy. Nephron 1996; 74: 734-5. |
| (19) |
Yuasa S., Hashimoto M., Yura Y., et al. Antineutrophil
Cyioplasmic Antibodies (ANCA)-Associated Crescentic Glomerulonephritis and
Propylthiouracil Therapy. Nephron 1996; 73: 101-3. |
| (20) |
Saeki T., Miyamura S., Nakano M., Arakawa M.(A case of Graves' disease
with MPO-ANCA-associated glomerulonephritis during propylthiouracil(PTU)
therapy following interstitial pneumonitis.) Nippon Jinzo Gakkai Shi 1997;
39(2): 167-71. |
| (21) |
Kawachi Y., Nnkaga H., Hoshino M., Iwata M., Otsnka
F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole.
Clin Exp Dermatol 1995; 20(4): 345-7. |
| (22) |
Cooper DS. Antithyroid Drugs. N Eng J Med 1984; 311(21): 1353-1362. |
| (23) |
Vasily DB, Tyler WB. Propylthiouracil-Induced Cutaneous
Vasculitis. JAMA 1980; 243(5): 458-461. |
| (24) |
Houston BD., Crouch ME., Brick JE., DiBartolomeo AG. Apparent vasculitis
associated with propylthiouracil use. Arthritis and Rheum 1979; 22: 925-8. |
| (25) |
Ekenstam E., Callen JP. Cutaneous leukocyioclastic vasculitis:
clinical and laboratory features of 82 patients seen in private practice.
Arch Dermatol 1984;120: 484-9. |
| (26) |
Sanchez NP., Van Hale HM. Su wrD. Clinical and histopathologic spectum
of necrotizing vasculitis: report of findings in 101 cases. Arch Dermatol
1985; 121: 220-4. |
| (27) |
Lam DCC., Lindsay RH. Accumulation of 2-[14C] propylthiouracil
in human polymorphonuclear leukocytes. Biochem Phannacol 1979; 28: 2289-96. |
| (28) |
Lee H., Hirouchi M., Hosokawa M., Sayo H.. Kohno M, Kariya K. Inactivation
of peroxidase of rat bone marrow by repeated administration of propylthiouracil
is accompanied by a change in the heme structure. Biochem Pharmacol 1988;
37: 2151-3. |
| (29) |
Almoroth G., Enestrom S., Hed J., Samuelsson I., Sjostrom
P. Autoantibodies to leucocyie antigens in hydralazine-associated nephritis.
J Intern Med 1992; 231(1): 37-42. |
| (30) |
Nassberger L., Sjoholm AG., Jonsson H., Sturfelt G., Akesson A. Autoantibodies
'against neutrophil cyioplasm components in systemic lupus erythematous
and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81(3): 380-3. |
| (31) |
Salemo SM., Onnseth EJ., Roth BJ., Meyer CA., Christensen
ED., Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis
mimicking clinical features of Wegener's. Chest 1996; 110(2): 556-9. |
| (32) |
Hill ME., Gordon C.. Situnayake RD.. Heath DA. Sulfasalazine induced seizures
and dysphasia. J Rheumatol 1994; 21(4): 748-9. |
| (33) |
Elkayam O., Yaron M., Caspi D. Minocycline induced arthritis
associated with fever, Iivedo reticularis, and pANCA. Ann Rhem Dis 1996;
55(10): 769-71. |